GYN&FORM
ActiveSummary
GYN&FORM has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €192,718 and a net result of €99,386. Equity is growing by about 59% per year across the filed financial years. Its solvency ranks better than 62% of 2,944 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
24-08
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format · 24 days late
2025
31-12
Financial
Highest result from 2022 to 2025net €99,386 ▲193%
Operating result €158,990, net result €99,386, both a record.
31-12
Financial
Equity above €150,000equity €192,718 ▲105%
A profit in every financial year since 2022 builds equity to €192,718.
28-07
NBB filing
Annual accounts filed
financial year 2024 · full format
2024
31-08
NBB filing
Annual accounts filed
financial year 2023 · full format · 31 days late
2023
31-12
Financial
Weakest financial yearnet €17,977 ▼56.6%
Net result drops to €17,977, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity more than doubledcurrent ratio 4.79
Current ratio from 1.91 to 4.79; short-term debt falls from €44,380 to €15,168.
11-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.